Search Prime Grants

U01EB028235

Cooperative Agreement

Overview

Grant Description
Microsystems imaging system for epithelial-derived cancer heterogeneity.
Funding Goals
TO SUPPORT HYPOTHESIS-, DESIGN-, TECHNOLOGY-, OR DEVICE-DRIVEN RESEARCH RELATED TO THE DISCOVERY, DESIGN, DEVELOPMENT, VALIDATION, AND APPLICATION OF TECHNOLOGIES FOR BIOMEDICAL IMAGING AND BIOENGINEERING. THE PROGRAM INCLUDES BIOMATERIALS (BIOMIMETICS, BIOPROCESSING, ORGANOGENESIS, REHABILITATION, TISSUE ENGINEERING, IMPLANT SCIENCE, MATERIAL SCIENCE, INTERFACE SCIENCE, PHYSICS AND STRESS ENGINEERING, TECHNOLOGY ASSESSMENT OF MATERIALS/DEVICES), BIOSENSORS/BIOTRANSDUCERS (TECHNOLOGY DEVELOPMENT, TECHNOLOGY ASSESSMENT, DEVELOPMENT OF ALGORITHMS, TELEMETRY), NANOTECHNOLOGY (NANOSCIENCE, BIOMIMETICS, DRUG DELIVERY SYSTEMS, DRUG BIOAVAILABILITY, MICROARRAY/COMBINATORIAL TECHNOLOGY, GENETIC ENGINEERING, COMPUTER SCIENCE, TECHNOLOGY ASSESSMENT), BIOINFORMATICS (COMPUTER SCIENCE, INFORMATION SCIENCE, MATHEMATICS, BIOMECHANICS, COMPUTATIONAL MODELING AND SIMULATION, REMOTE DIAGNOSIS AND THERAPY), IMAGING DEVICE DEVELOPMENT, BIOMEDICAL IMAGING TECHNOLOGY DEVELOPMENT, IMAGE EXPLOITATION, CONTRAST AGENTS, INFORMATICS AND COMPUTER SCIENCES RELATED TO IMAGING, MOLECULAR AND CELLULAR IMAGING, BIOELECTRICS/BIOMAGNETICS, ORGAN AND WHOLE BODY IMAGING, SCREENING FOR DISEASES AND DISORDERS, AND IMAGING TECHNOLOGY ASSESSMENT AND SURGERY (TECHNIQUE DEVELOPMENT AND TECHNOLOGY DEVELOPMENT).
Place of Performance
Michigan United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/24 to 05/31/25 and the total obligations have increased 397% from $580,711 to $2,886,396.
Regents Of The University Of Michigan was awarded Microsystems imaging system for epithelial-derived cancer heterogeneity Cooperative Agreement U01EB028235 worth $2,886,396 from the National Institute of Biomedical Imaging and Bioengineering in September 2019 with work to be completed primarily in Michigan United States. The grant has a duration of 5 years 8 months and was awarded through assistance program 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health. The Cooperative Agreement was awarded through grant opportunity Bioengineering Research Partnerships (U01 Clinical Trial Optional).

Status
(Complete)

Last Modified 9/24/25

Period of Performance
9/1/19
Start Date
5/31/25
End Date
100% Complete

Funding Split
$2.9M
Federal Obligation
$0.0
Non-Federal Obligation
$2.9M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01EB028235

Transaction History

Modifications to U01EB028235

Additional Detail

Award ID FAIN
U01EB028235
SAI Number
U01EB028235-555872981
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Funding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Awardee UEI
GNJ7BBP73WE9
Awardee CAGE
03399
Performance District
MI-90
Senators
Debbie Stabenow
Gary Peters

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Health and Human Services (075-0898) Health research and training Grants, subsidies, and contributions (41.0) $2,903,555 100%
Modified: 9/24/25